| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5207727
Max Phase: Preclinical
Molecular Formula: C20H13N3
Molecular Weight: 295.35
Associated Items:
Representations
Canonical SMILES: c1ccc(-c2nc3ccccc3c3cc4ccccn4c23)nc1
Standard InChI: InChI=1S/C20H13N3/c1-2-9-17-15(8-1)16-13-14-7-4-6-12-23(14)20(16)19(22-17)18-10-3-5-11-21-18/h1-13H
Standard InChI Key: LOYNLNJIDYTKEU-UHFFFAOYSA-N
Associated Targets(non-human)
HT-22 3261 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 295.35 | Molecular Weight (Monoisotopic): 295.1109 | AlogP: 4.70 | #Rotatable Bonds: 1 |
| Polar Surface Area: 30.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 2.63 | CX LogP: 3.99 | CX LogD: 3.99 |
| Aromatic Rings: 5 | Heavy Atoms: 23 | QED Weighted: 0.45 | Np Likeness Score: -0.91 |
References
| 1. Kim K, Lee JH, Kim S, Lee S, Lee D, Kim HY, Kim I, Kim Y.. (2021) Anti-amyloidogenic indolizino[3,2-c]quinolines as imaging probes differentiating dense-core, diffuse, and coronal plaques of amyloid-β., 12 (11.0): [PMID:34825188] [10.1039/D1MD00030F] |
Source
Source(1):